Ariel Angel
Mapi Pharma (Israel)(IL)
Publications by Year
Research Areas
Extracellular vesicles in disease, Nanoparticle-Based Drug Delivery, Alzheimer's disease research and treatments, Mitochondrial Function and Pathology, Retinal Development and Disorders
Most-Cited Works
- → In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles(2017)393 cited
- → Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders(2019)381 cited
- → Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia‐reperfusion injury in rats(2006)50 cited
- → Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model(2017)48 cited
- → Caspase-6 Knockout in the 5xFAD Model of Alzheimer’s Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks(2020)32 cited
- → Color and contrast vision in mouse models of aging and Alzheimer’s disease using a novel visual-stimuli four-arm maze(2021)29 cited
- → The Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo(2019)18 cited
- → Caspase-6 knock-out using CRISPR/Cas9 improves cognitive behavior in the 3xTg mouse model of Alzheimer's disease(2018)6 cited
- → Combined Gene Therapy to Reduce the Neuronal Damage in the Mouse Model of Focal Ischemic Injury(2018)6 cited
- → Reply to “Comment on ‘In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles’”(2018)2 cited